Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Therapy for Refractory H. Pylori
NCT00885417Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Primary endpoint: Eradication rate. Started Apr 2009; status: completed.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00885417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885417.